The global empty capsule market is poised for significant growth and is projected to reach USD 2,956.6 million in 2024. The sales of empty capsules are expected to witness a robust CAGR of 8.0% from 2024 to 2034. By 2034, the demand for empty capsules is anticipated to reach a valuation of USD 6,378.6 million. In the pharmaceutical sector, empty capsules are commonly used to encapsulate a variety of medications. As the world’s population grows and ages, anticipates the demand for pharmaceutical items, boosting the empty capsule industry.
Capsule production technology improvements, including capsule filling machines and quality control systems, are helping to improve the efficiency and dependability. The rise of e-commerce has had an impact on a variety of businesses, including pharmaceuticals and nutraceuticals. Online sales channels have grown in popularity for customers to purchase empty capsules, providing convenience and various options.
Price fluctuations in raw materials, such as gelatin or vegetarian substitutes used in capsule production, can impact manufacturing costs. Increased costs reduce business margins and competition in the empty capsule market. Developing environmental awareness creates a demand for more sustainable and eco-friendly packaging options. Manufacturers of empty capsules are pressured to implement eco-friendly techniques or create capsule materials with a low environmental impact.
Regional Outlook:
The North American empty capsule market is expected to dominate because of a large elderly population and established distribution networks. The expanding pharmaceutical industry accelerates market expansion of empty capsules.
Europe is likely to hold a significant share due to high product availability, rising disease prevalence, and increased research and development. The United Kingdom empty pill market had a considerable share, while the demand for empty capsules rapidly expanded in Germany.
The Asia Pacific empty capsule market is likely to develop quickly between 2024 and 2034 due to the growing patient pool. The increase in healthcare infrastructure expenses is further expected to stimulate market expansion. China has an enormous market share, while India is swiftly expanding in Asia Pacific.
“The empty pill market is expected to expand due to increased demand for medications and nutraceuticals. The growing emphasis on personalized medicine and new drug delivery technologies expands potential while encouraging market expansion and rivalry among vendors.”, opines an FMI analyst.
Elevate Your Strategy with Full Report Access – Get It Now
Key Takeaways:
- The gelatin-based capsules segment in the product type category to grab a share of 59% from 2024 to 2034.
- In the raw material category, the type-B segment is to acquire a share of 28.2% between 2024 and 2034.
- The size “0” capsules segment in the capsule size category to grab a share of 20.4% from 2024 to 2034.
- A 90.3% market share is expected for the oral administration sector in the route of administration category between 2024 and 2034.
- The United States sales of empty capsules are anticipated to surge at a CAGR of 8.8% in 2024.
- Germany empty capsule market is to develop at a CAGR of 8.4% through 2024.
- Canada empty capsule sales are expected to surge at a CAGR of 6.2% from 2024 to 2034.
- Italy empty capsule industry is anticipated to boost at a CAGR of 3.2% between 2024 and 2034.
- Japan empty pill market is likely to exhibit a CAGR of 7.8% from 2024 to 2034.
Competitive Landscape:
Leading manufacturers of empty capsules have secured their positions in the industry owing to increased research funding and a superior distribution network.
Due to the increased awareness of empty capsules, Asia Pacific is seeing the rise of a few small and medium-sized companies. Key empty capsule vendors engage in strategic alliances and product launches to maintain their competitive market positions.
Novel Developments:
- In February 2023, Vivion, Inc., a global supplier of ingredient solutions, announced the debut of a new product range of empty gelatin, HPMC, and pullulan capsules.
- CapsCanada, a Lyfe Group firm, announced in March 2021 the debut of a new liquid-filled hard capsule manufacturing service.
- Reddy Laboratories gained license from the United States Food and Drug Administration (USFDA) in August 2020 to manufacture generic Penicillamine capsules used to treat Wilson’s disease and cystinuria.
Prominent Empty Capsule Manufacturers:
- ACG Worldwide
- Capsugel
- Qualicaps Inc.
- Bright Pharma Caps Inc.
- Sunil Healthcare Ltd.
- CapsCanada Corporation
- Roxlor LLC
- Snail Pharma Industry Co. Ltd.
- Suheung Co. Ltd.
- Medi-Caps Ltd.
Key Segments
By Product Type:
- Gelatin Based Capsules
- Vegetarian Based Capsules
By Raw Material:
- Type-A
- Type-B Gelatin
- Fish Bone Gelatin
- Hydroxy Propyl Methyl Cellulose (HPMC)
- Starch Materials
- Pullulan
By Capsule Size:
- Size “000” Empty Capsules
- Size “00” Empty Capsules
- Size “0” Empty Capsules
- Size “1” Empty Capsules
- Size “2” Empty Capsules
- Size “3” Empty Capsules
- Size “4” Empty Capsules
- Size “5” Empty Capsules
By Route of Administration:
- Oral Administration
- Inhalation Administration
By End User:
- Pharmaceutical Companies
- Cosmetic and Nutraceutical Companies
- Clinical Research Organizations
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia and Pacific
- The Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
